Brief: Lyra Therapeutics Reports Third Quarter 2022 Financial Results, Provides Corporate Update

Lyra Therapeutics

08/11/2022 23:04

Nov 8 (Reuters) - Lyra Therapeutics Inc  LYRA.O :
    * LYRA THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * LYRA - PRIORITIZING ENLIGHTEN I PIVOTAL PHASE 3 TRIAL OF
LYR-210
IN CHRONIC RHINOSINUSITIS; STUDY ON TRACK, WITH FULL ENROLLMENT
ANTICIPATED MID-2023
    * QTRLY EARNINGS PER SHARE $0.40
    * Q3 EARNINGS PER SHARE VIEW $-0.44 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6z6lrq 
Further company coverage:  LYRA.O 
 ((Reuters.Briefs@thomsonreuters.com;))